Anton V Bryksin

Dr. Anton V Bryksin


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 January 2023 in Marine Drugs
Verified
Journal Article
Open access
PDF file
JDJessica M. Deutsch
Jessica M. Deutsch
MGMadison O. Green
Madison O. Green
PAPriyanka Akavaram
Priyanka Akavaram
ADAshleigh C. Davis
Ashleigh C. Davis
SDSarth S. Diskalkar
Sarth S. Diskalkar
VAVinayak Agarwal
Vinayak Agarwal
Sponges are the richest source of bioactive organic small molecules, referred to as natural products, in the marine environment. It is well established that laboratory culturing-resistant symbiotic bacteria residing within the eukaryotic sponge host matrix often synthesize the natural products that are detected in the sponge tissue extracts. However, the contributions of the culturing-amenable commensal bacteria that are also associated with the sponge host to the overall metabolome of the sponge holobiont are not well defined. In this study, we cultured a large library of bacteria from three marine sponges commonly found in the Florida Keys. Metabolomes of isolated bacterial strains and that of the sponge holobiont were compared using mass spectrometry to reveal minimal metabolomic overlap between commensal bacteria and the sponge hosts. We also find that the phylogenetic overlap between cultured commensal bacteria and that of the sponge microbiome is minimal. Despite these observations, the commensal bacteria were found to be a rich resource for novel natural product discovery. Mass spectrometry-based metabolomics provided structural insights into these cryptic natural products. Pedagogic innovation in the form of laboratory curricula development is described which provided undergraduate students with hands-on instruction in microbiology and natural product discovery using metabolomic data mining strategies.

7 January 2026 in Advanced Science
Verified
Journal Article
Open access
HLHohyun Lee
Hohyun Lee
VMVictor Menezes
Victor Menezes
SZShiqin Zeng
Shiqin Zeng
CKChulyong Kim
Chulyong Kim
CBCynthia M. Baseman
Cynthia M. Baseman
CACostas Arvanitis
Costas Arvanitis
The blood‐brain barrier (BBB) renders the delivery of nanomedicine in the brain ineffective and the detection of circulating disease‐related DNA from the brain unreliable. Here, we demonstrate that microbubble‐enhanced focused ultrasound (MB‐FUS) mediated BBB opening, supported by large‐data models predict sonication regimens for safe and effective BBB opening. Importantly, a closed‐loop MB‐FUS controller augmented by machine learning (ML‐CL) expands the treatment window, as compared to conventional controllers, by persistently and proactively maximizing the BBB permeability while preventing tissue damage. By successfully scaling up from mice to rats and from healthy to diseased brains (glioma), ML‐CL rendered the BBB permeable to large nanoparticles and markedly improved the release and detection of reporter gene DNA from tumors in blood. Together, our findings reveal the potential of data‐driven feedback to support the development of next‐generation AI‐powered ultrasound systems for safe, robust, and efficient nanotheranostic targeting and treatment of brain diseases.

21 September 2024 in Viruses
Verified
Journal Article
Open access
PDF file
MFMichael Lee Farrell
Michael Lee Farrell
ABAnton V Bryksin
Anton V Bryksin
EREmily Ryan
Emily Ryan
JLJessica Lin
Jessica Lin
NDNaima Djeddar
Naima Djeddar
MSMichael P Shannon
Michael P Shannon
At the beginning of the COVID-19 pandemic, the Georgia Institute of Technology made the decision to keep the university doors open for on-campus attendance. To manage COVID-19 infection rates, internal resources were applied to develop and implement a mass asymptomatic surveillance program. The objective was to identify infections early for proper follow-on verification testing, contact tracing, and quarantine/isolation as needed. Program success depended on frequent and voluntary sample collection from over 40,000 students, faculty, and staff personnel. At that time, the nasopharyngeal (NP) swab, not saliva, was the main accepted sample type for COVID-19 testing. However, due to collection discomfort and the inability to be self-collected, the NP swab was not feasible for voluntary and frequent self-collection. Therefore, saliva was selected as the clinical sample type and validated. A saliva collection kit and a sample processing and analysis workflow were developed. The results of a clinical sample-type comparison study between co-collected and matched NP swabs and saliva samples showed 96.7% positive agreement and 100% negative agreement. During the Fall 2020 and Spring 2021 semesters, 319,988 samples were collected and tested. The program resulted in maintaining a low overall mean positivity rate of 0.78% and 0.54% for the Fall 2020 and Spring 2021 semesters, respectively. For this high-throughput asymptomatic COVID-19 screening application, saliva was an exceptionally good sample type.

7 May 2025 in bioRxiv
Verified
Preprint
Open access
PDF file
HLHohyun Lee
Hohyun Lee
VMVictor Menezes
Victor Menezes
SZShiqin Zeng
Shiqin Zeng
CKChulyong Kim
Chulyong Kim
CBCynthia M. Baseman
Cynthia M. Baseman
CACostas Arvanitis
Costas Arvanitis
The blood-brain barrier (BBB) renders the delivery of nanomedicine in the brain ineffective and the detection of circulating disease-related DNA from the brain unreliable. Here, we show that the acoustic emission content of focused ultrasound-controlled microbubble dynamics (MB-FUS) incorporates precursor signals that allow large-data models to predict sonication regimens for safe and effective BBB opening. Crucially, closed-loop MB-FUS controller augmented by machine learning (ML-CL) expands the treatment window (4-fold), as compared to conventional controllers, by persistently and proactively maximizing the BBB permeability while preventing tissue damage. By successfully scaling up from mice to rats and from healthy to diseased brains (glioma), ML-CL rendered the BBB permeable to large nanoparticles and markedly improved the release and detection of tumor DNA in plasma. Together, our findings reveal the potential of data-driven feedback to support the development of next-generation AI-powered ultrasound systems for safe, robust, and efficient nanotheranostic targeting of brain diseases.

1 January 2026 in The Analyst
Verified
Journal Article
Open access
MAMary Catherine Adams
Mary Catherine Adams
NDNaima Djeddar
Naima Djeddar
ABAnton V Bryksin
Anton V Bryksin
VMValeria Milam
Valeria Milam
Graphic overview of next generation sequencing analysis of DNA libraries reveals artifacts included in data passing filtering steps while valid sequence data was filtered out.